Name: Immune Checkpoint Biology in Health and Disease (Volume 382) (International Review of Cell and Molecular Biology, Volume 382) (en Inglés)
Price: 683.41 PEN
Availability: InStock
Author: Galluzzi Lorenzo,Garg Abhishek
ISBN: 9780443135736

portada Immune Checkpoint Biology in Health and Disease (Volume 382) (International Review of Cell and Molecular Biology, Volume 382) (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Galluzzi Lorenzo,Garg Abhishek

Idioma

Inglés

N° páginas

277

Encuadernación

Nuevo

ISBN13

9780443135736

N° edición

Immune Checkpoint Biology in Health and Disease (Volume 382) (International Review of Cell and Molecular Biology, Volume 382) (en Inglés)

Galluzzi Lorenzo,Garg Abhishek (Autor) · Academic Press · Nuevo

Libro Nuevo

S/ 683,41

S/ 1.366,82

Ahorras: S/ 683,41

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Miércoles 21 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Immune Checkpoint Biology in Health and Disease (Volume 382) (International Review of Cell and Molecular Biology, Volume 382) (en Inglés)"

Immune Checkpoint Biology in Health and Disease, Volume 382 provides in-depth reviews on the latest progress concerning research on immune-checkpoint biology and its immunotherapeutic implications, especially in cancer. Topics connected to immune-checkpoint biology covered in this volume include Novel technologies for applying immune checkpoint blockers, Next-generation deconvolution of transcriptomic data to investigate the tumor microenvironment, Immune checkpoints targeting dendritic cells for antibody-based modulation in cancer, Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients, and much more. Other sections cover Recent advancements in tumor microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis, Immune Modulation During Anti-Cancer Radio(immuno)therapy, and Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy.